The effect of romosozumab and denosumab on bone mineral density in patients with rheumatoid arthritis
Not Applicable
Recruiting
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000049741
- Lead Sponsor
- Tokyo Metropolitan Tama medical center
- Brief Summary
Patients were enrolled to 26 cases in romosozumab group and 24 cases in denosumab group. Data were input to excel and are going to be analyzed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who are not diagnosed with rheumatoid arthritis or osteoporosis. 2. Patients with a history of ischemic heart disease or cerebrovascular disease within the past 1 year are excluded from the romosozumab group. 3.Patients who are allergic to romosozumab or denosumab. 4.Patients who are judged to be unsuitable as subjects by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method